Published in Gastrointest Endosc on November 01, 2008
Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol (2016) 0.80
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc (2008) 1.96
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med (2003) 3.30
Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77
Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol (2006) 2.65
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol (2014) 2.41
Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study. Gastrointest Endosc (2010) 2.28
Increased risk of colorectal cancer after obesity surgery. Ann Surg (2013) 2.17
Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. BMJ (2010) 2.11
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control (2005) 1.80
Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology (2002) 1.76
A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol (2009) 1.71
Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer (2006) 1.59
Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg (2010) 1.50
Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand J Gastroenterol (2012) 1.49
Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer (2008) 1.48
Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol (2013) 1.48
Risk factors for esophageal adenocarcinoma after antireflux surgery. Ann Surg (2013) 1.44
Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg (2006) 1.44
[How resident physicians milestones for medical science are reached with high quality]. Lakartidningen (2013) 1.39
Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol (2013) 1.39
Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg (2007) 1.38
Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia. World J Surg (2008) 1.38
Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol (2005) 1.34
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer (2007) 1.27
Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol (2011) 1.25
Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg (2006) 1.24
Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer (2008) 1.22
Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev (2004) 1.22
Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology (2006) 1.22
Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18
Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev (2005) 1.14
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11
Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer (2002) 1.08
The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis (2006) 1.07
Clinical management of obese patients with cancer. Nat Rev Clin Oncol (2013) 1.06
Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2003) 1.06
Increased population prevalence of reflux and obesity in the United Kingdom compared with Sweden: a potential explanation for the difference in incidence of esophageal adenocarcinoma. Eur J Gastroenterol Hepatol (2011) 1.06
The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer (2009) 1.05
Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg (2005) 1.05
Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer (2008) 1.04
Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer (2010) 1.03
Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery. JAMA Surg (2013) 1.02
The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest (2006) 1.00
Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol (2012) 0.99
Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer (2008) 0.96
Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med (2013) 0.93
Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter (2007) 0.93
Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. Cancer Causes Control (2005) 0.92
Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PLoS One (2012) 0.90
Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology (2008) 0.88
Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study). Clin Gastroenterol Hepatol (2007) 0.88
Airborne exposures and risk of gastric cancer: a prospective cohort study. Int J Cancer (2007) 0.88
Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery (2012) 0.87
Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncol (2013) 0.87
The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study. Am J Surg (2013) 0.87
Education level and survival after oesophageal cancer surgery: a prospective population-based cohort study. BMJ Open (2013) 0.86
Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev (2008) 0.86
Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2006) 0.86
Risk factors and chemoprevention in Barrett's esophagus--an update. Scand J Gastroenterol (2012) 0.85
Factors associated with early recurrence and death after esophagectomy for cancer. J Surg Oncol (2013) 0.84
Job strain and risk of esophageal and cardia cancers. Cancer Epidemiol (2009) 0.83
The relation between body mass and gastro-oesophageal reflux. Best Pract Res Clin Gastroenterol (2004) 0.83
Reoperation after oesophageal cancer surgery in relation to long-term survival: a population-based cohort study. BMJ Open (2014) 0.82
Socio-demographic and geographical factors in esophageal and gastric cancer mortality in Sweden. PLoS One (2013) 0.82
Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study. World J Surg (2006) 0.82
Twelve tips for conducting a postgraduate course on study design and study protocol writing for the medical profession. Med Teach (2011) 0.82
Physical activity, obesity and gastroesophageal reflux disease in the general population. World J Gastroenterol (2012) 0.82
Oesophageal adenocarcinoma: the new epidemic in men? Maturitas (2011) 0.81
Maternal tobacco smoking, obesity, and low socioeconomic status during early pregnancy in the etiology of esophageal atresia. J Pediatr Surg (2008) 0.81
Dietary intake of lignans and risk of adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control (2012) 0.81
[Validate more! Common interest in quality assurance of Swedish health data registries]. Lakartidningen (2012) 0.81
Salt and gastric adenocarcinoma: a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev (2008) 0.81
Antireflux stent versus conventional stent in the palliation of distal esophageal cancer. A randomized, multicenter clinical trial. Scand J Gastroenterol (2010) 0.81
Surgeon volume is a poor proxy for skill in esophageal cancer surgery. Ann Surg (2009) 0.81
Increased risk of Barrett's esophagus among individuals born preterm or small for gestational age. Clin Gastroenterol Hepatol (2013) 0.80
Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J (2010) 0.80
Cardiovascular disease and risk of acute pancreatitis in a population-based study. Pancreas (2013) 0.80
Abdominal fat and male excess of esophageal adenocarcinoma. Epidemiology (2013) 0.80
Comorbidities and Risk of Complications After Surgery for Esophageal Cancer: A Nationwide Cohort Study in Sweden. World J Surg (2015) 0.80
High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study. Drugs Aging (2011) 0.79
Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis. Int J Cancer (2013) 0.79
Use of non-steroidal anti-inflammatory drugs and proton pump inhibitors in correlation with incidence, recurrence and death of peptic ulcer bleeding: an ecological study. BMJ Open (2013) 0.79
Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial. World J Gastrointest Endosc (2012) 0.79
The impact of volume on outcomes after oesophageal cancer surgery. ANZ J Surg (2010) 0.79
Influence of maternal parity, age, and ethnicity on risk of esophageal atresia in the infant in a population-based study. J Pediatr Surg (2008) 0.79
Risk of esophagitis among individuals born preterm or small for gestational age. Clin Gastroenterol Hepatol (2012) 0.79
Environmental factors in the etiology of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol (2008) 0.78
Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (2009) 0.78
Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding. BMC Pharmacol Toxicol (2014) 0.78
Aspects of esophageal atresia in a population-based setting: incidence, mortality, and cancer risk. Pediatr Surg Int (2011) 0.78
Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden. Eur J Cancer (2011) 0.78
Tumour staging of oesophageal cancer in the Swedish Cancer Registry: A nationwide validation study. Acta Oncol (2015) 0.78
Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age. Eur J Cancer (2013) 0.78
Reproductive history and risk of colorectal adenocarcinoma. Epidemiology (2014) 0.78
Supportive care for patients with oesophageal and other upper gastrointestinal cancers: The role of a specialist nurse in the team. Eur J Oncol Nurs (2006) 0.78
Dietary proportions of carbohydrates, fat, and protein and risk of oesophageal cancer by histological type. PLoS One (2013) 0.77
Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden. Int J Cancer (2011) 0.77